MediPharm Labs Enters Contract with Supreme Cannabis
MediPharm Labs Enters Contract with Supreme Cannabis
Perth, Nov 15, 2018 AEST (ABN Newswire) - MMJ Group Holdings Limited (ASX:MMJ) (OTCMKTS:MMJJF) ("MMJ") is pleased to attach a copy of a news release by MediPharm Labs Inc ("MediPharm Labs") (CVE:LABS) announcing that it has entered into a 3-year cannabis concentrate program agreement with Supreme Cannabis Company Inc ("Supreme Cannabis") (CVE:FIRE).

MMJ owns 5.2 million shares and 2.9 million warrants (exercisable at CAD$1.20 per share by October 2020) in MediPharm Labs.

To view the news release, please visit:
http://abnnewswire.net/lnk/873PJPU0


About MMJ Group Holdings Ltd

Phytotech Medical ASX:PYL

MMJ Group Holdings Ltd (ASX:MMJ) is a global cannabis investment company. MMJ owns a portfolio of minority investments and aims to invest across the full range of emerging cannabis-related sectors including healthcare, technology, infrastructure, logistics, processing, cultivation, equipment and retail. For MMJ's latest investor presentation and news, please visit: http://www.mmjphytotech.com.au/investors/

   


Contact

Investor and Media Enquiries:
Jason Conroy
Chief Executive Officer
T: +61-2-8098-0819
E: info@mmjgh.com.au



Related Companies

Supreme Cannabis Company Inc
MMJ Group Holdings Ltd   
MediPharm Labs Corp.

ABN Newswire This Page Viewed:  (Last 7 Days: 138) (Last 30 Days: 1782) 
ANALYTICS: LOGIN HERE

MMJ Group Holdings Ltd NEWS: RECENT VISITS (46109)

Research Report

Social Media